Filtros de búsqueda

Lista de obras de

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation

artículo científico publicado en 2015

A combined biomarker and clinical panel for chronic graft versus host disease diagnosis

artículo científico publicado en 2016

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

artículo científico publicado en 2002

A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

artículo científico publicado en 2011

A novel soluble form of Tim-3 associated with severe graft-versus-host disease

artículo científico publicado en 2013

A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation

artículo científico publicado en 2005

A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease

artículo científico publicado en 2005

A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells

artículo científico publicado en 2011

A survey of diagnosis, management, and grading of chronic GVHD.

artículo científico publicado en 2002

Activation and Expansion of CD8+ T Effector Cells in Patients with Chronic Graft-versus-Host Disease ⬇️

artículo científico publicado el 24 de marzo de 2011

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial

artículo científico publicado en 2019

Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses.

artículo científico publicado en 2006

Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2003

Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities ⬇️

artículo científico publicado el 6 de octubre de 2010

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

artículo científico publicado en 2009

Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects

artículo científico publicado en 2013

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

artículo científico publicado en 2020

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

scientific article published on 14 August 2003

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

artículo científico publicado en 2017

An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation

scientific article published on 05 May 2018

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Wo

artículo científico publicado en 2006

Application of CIBMTR risk score to NIH chronic GVHD at individual centers

artículo científico publicado en 2014

Assessment of joint and fascia manifestations in chronic graft-versus-host disease

artículo científico publicado en 2014

Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease

artículo científico publicado en 2017

Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes

artículo científico publicado en 2017

Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease

artículo científico publicado en 2014

Bandage Soft Contact Lenses for Ocular Graft-versus-Host Disease

artículo científico publicado en 2015

Biomarker Panel for Chronic Graft-Versus-Host Disease

artículo científico publicado en 2016

Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation.

artículo científico publicado en 2011

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials

artículo científico publicado en 2008

Clinical benefit of response in chronic graft-versus-host disease

artículo científico publicado en 2012

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

artículo científico publicado en 2014

Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors

artículo científico publicado en 2007

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

artículo científico publicado en 2011

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients

artículo científico publicado en 2019

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

scientific article published on 01 July 2002

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease

artículo científico publicado en 2010

Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis

scientific article published on 14 November 2018

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

artículo científico publicado en 2003

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome

artículo científico publicado en 2002

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

artículo científico publicado en 2012

Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up

artículo científico publicado en 2005

Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial

artículo científico publicado en 2000

Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

Delivering care to long-term adult survivors of hematopoietic cell transplantation

artículo científico publicado en 2012

Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation

artículo científico publicado en 2015

Diagnosis and clinical management of chronic graft-versus-host disease

artículo científico publicado en 2004

Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2020

Disability Related to Chronic Graft-versus-Host Disease

scientific article published on 24 October 2019

Disability related to chronic graft --host disease after alternative donor hematopoietic cell transplantation

scholarly article by Giancarlo Fatobene et al published April 2019 in Haematologica

Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose

artículo científico publicado en 2013

Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation

artículo científico publicado en 2009

Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease

artículo científico publicado en 2009

Duration of immunosuppressive treatment for chronic graft-versus-host disease

artículo científico publicado en 2004

Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT

artículo científico publicado en 2012

Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

artículo científico publicado en 2015

Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors

artículo científico publicado en 2018

Establishment of Definitions and Review Process for Consistent Adjudication of Cause-specific Mortality after Allogeneic Unrelated-donor Hematopoietic Cell Transplantation.

artículo científico publicado en 2015

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.

artículo científico publicado en 2009

Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation

artículo científico publicado en 2004

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

artículo científico publicado en 2009

Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease

artículo científico publicado en 2003

Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation

scientific article published on 01 March 2006

Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors

artículo científico publicado en 2010

Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children

scientific article published on 01 March 2002

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

artículo científico publicado en 2014

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease

artículo científico publicado en 2013

Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease

artículo científico publicado en 2015

Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation

artículo científico publicado en 2015

Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation.

artículo científico publicado en 2009

Genetic risk factors for sclerotic graft-versus-host disease

artículo científico publicado en 2016

Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor

artículo científico publicado en 2005

Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes

artículo científico publicado en 2008

Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.

artículo científico publicado en 2016

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

artículo científico publicado en 2011

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

artículo científico publicado en 2003

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2013

HLA-allele matched unrelated donors compared to HLA-matched sibling donors: role of cell source and disease risk category

artículo científico publicado en 2010

HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen

artículo científico publicado en 2003

Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium

artículo científico publicado en 2013

Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality

artículo científico publicado en 2002

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells

artículo científico publicado en 2016

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

artículo científico publicado en 2002

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.

artículo científico publicado en 2003

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

artículo científico publicado en 2006

How we treat chronic graft-versus-host disease

artículo científico publicado en 2014

IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice

artículo científico publicado en 2021

IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation

artículo científico publicado en 2009

Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life

artículo científico publicado en 2015

Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation ⬇️

artículo científico publicado el 26 de mayo de 2010

Improving hematopoietic cell transplant outcomes in a new era of genomic research

artículo científico publicado en 2009

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

artículo científico publicado en 2013

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research

artículo científico publicado en 2014

Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation

scientific article published on 01 May 2004

Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation

scientific article published on 02 December 2013

Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

artículo científico publicado en 2008

Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period

artículo científico publicado en 2012

Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation

artículo científico publicado en 2014

Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2015

Late cardiovascular complications after hematopoietic cell transplantation

artículo científico publicado en 2014

Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls.

artículo científico publicado en 2005

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation

artículo científico publicado en 2010

Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation.

artículo científico publicado en 2018

Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche

scientific article published in 2023

Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow

artículo científico publicado en 2012

Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study

artículo científico publicado en 2009

Lung function and long-term complications after allogeneic hematopoietic cell transplant

artículo científico publicado en 2009

Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group repor

artículo científico publicado en 2015

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

artículo científico publicado en 2006

Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors

artículo científico publicado en 2016

Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias

artículo científico publicado en 2002

Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation

artículo científico publicado en 2015

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report

artículo científico publicado en 2015

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report

artículo científico publicado en 2014

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

artículo científico publicado en 2015

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report

artículo científico publicado en 2015

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report

artículo científico publicado en 2006

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report

artículo científico publicado en 2015

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report

artículo científico publicado en 2016

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

artículo científico publicado en 2005

Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation

artículo científico publicado en 2011

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease

scientific article published on 11 May 2019

Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.

artículo científico publicado en 2010

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

artículo científico publicado en 2007

Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.

artículo científico publicado en 2007

Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation

artículo científico

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

artículo científico publicado en 2011

Pathogenic neutrophils in acute GVHD

artículo científico publicado en 2018

Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study ⬇️

artículo científico publicado el 24 de abril de 2003

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.

artículo científico publicado en 2014

Physical and mental recovery after hematopoietic stem cell transplantation.

artículo científico publicado en 2004

Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.

artículo científico publicado en 2013

Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment

artículo científico publicado en 2015

Poor agreement between clinician response ratings and calculated response measures in patients with chronic graft-versus-host disease

artículo científico publicado en 2012

Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia.

artículo científico publicado en 2017

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

artículo científico publicado en 2016

Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease

artículo científico publicado en 2017

Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease

artículo científico publicado en 2015

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

artículo científico publicado en 2014

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

artículo científico publicado en 2005

Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2009

Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia

artículo científico publicado en 2007

Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease

artículo científico publicado en 2002

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

artículo científico publicado en 2013

Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia

scientific article published on 01 February 2005

Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma

scientific article published on 01 May 2004

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

artículo científico publicado en 2006

Reduced mortality after allogeneic hematopoietic-cell transplantation

artículo científico publicado en 2010

Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation

artículo científico publicado en 2015

Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia

artículo científico publicado en 2020

Replication of associations between genetic polymorphisms and chronic graft-versus-host disease

artículo científico publicado en 2016

Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation

artículo científico publicado en 2015

Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease

artículo científico publicado en 2013

Risk factors for depression and fatigue among survivors of hematopoietic cell transplantation

artículo científico publicado en 2016

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2009

Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation

scientific article published on 10 July 2003

Secondary treatment of acute graft-versus-host disease: a critical review

artículo científico publicado en 2012

Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors

artículo científico publicado en 2008

Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease

artículo científico publicado en 2017

Success of allogeneic marrow transplantation for children with severe aplastic anaemia

artículo científico publicado en 2012

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

scientific article published on 21 January 2020

Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia

artículo científico publicado en 2015

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma

scientific article published on 09 November 2017

The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index

scientific article published on 05 August 2019

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

artículo científico publicado en 2002

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report

artículo científico publicado en 2006

Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.

artículo científico publicado en 2008

Treatment of chronic graft-versus-host disease: Past, present and future

artículo científico publicado en 2011

Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia

artículo científico publicado en 2005

Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease

artículo científico publicado en 2007

Validation of measurement scales in ocular graft-versus-host disease

artículo científico publicado en 2011

Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation

artículo científico publicado en 2017

Visual acuity and anterior segment findings in chronic graft-versus-host disease

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda